Fluconazole-Responsive Transcriptional Signatures in Oral Yeast Isolates: Comparative Analysis of Candida albicans, Candida tropicalis, and Nakaseomyces glabratus
Keywords:
oral Candida, Candida albicans, Candida tropicalis, Nakaseomyces glabratus, fluconazole, ERG11, efflux, RT-qPCRAbstract
Background: Oral Candida populations include C. albicans and clinically relevant non-albicans species whose fluconazole responses are mediated by sterol-pathway and efflux mechanisms. Oral mycology studies have documented C. albicans, C. tropicalis, and N. glabratus (C. glabrata) among recovered yeasts. Methods: Ninety oral yeast isolates (30 per species) from private diagnostic laboratory collections were examined. Fluconazole minimum inhibitory concentrations (MICs) were determined by broth microdilution. Matched cultures were then incubated without drug or with 0.5× isolate-specific MIC fluconazole for 4 h. RT-qPCR quantified two targets per species: ERG11 and MDR1 in C. albicans, ERG11 and ERG3 in C. tropicalis, and CDR2 and ERG11 in N. glabratus. Published primer sets produced amplicons of 96-149 bp and expression was normalized to ACT1 or URA3. Results: N. glabratus showed the highest fluconazole MIC distribution. Subinhibitory fluconazole induced all six target genes, with the greatest response observed for N. glabratus CDR2, followed by C. tropicalis ERG11 and C. albicans ERG11. Reference-gene Ct values remained stable. Conclusion: The three oral yeast species displayed distinct but coordinated transcriptional responses to fluconazole, supporting the value of isolate-only phenotypic and molecular profiling when clinical histories are unavailable.